Cytomel (Liothyronine) Cost in Georgia 2026

What Liothyronine Is and Why the Price Matters

Liothyronine is the synthetic form of triiodothyronine (T3), the more metabolically active of the two principal thyroid hormones. Doctors prescribe it for hypothyroidism, T3 suppression testing, myxedema coma, and sometimes as an adjunct when levothyroxine monotherapy leaves patients with residual symptoms. The FDA-approved brand name is Cytomel, manufactured by Pfizer, and multiple generic versions are available. The FDA labeling page for Cytomel is maintained at the FDA's accessdata portal.

Cost matters here because liothyronine is not a one-time purchase. Thyroid conditions are chronic, so a $30, $85 monthly gap between options compounds across years. Georgia residents also face specific Medicaid and insurance rules that can make out-of-pocket costs higher than the national average for certain populations.

A landmark 1999 trial by Bunevicius et al. published in the New England Journal of Medicine (N=33) found that replacing 50 mcg of levothyroxine with 12.5 mcg of liothyronine improved mood and neuropsychological function compared with levothyroxine alone, stoking physician and patient interest in T3 therapy that continues today. [1] That interest directly drives prescription volume and, by extension, the pricing environment Georgia patients face.

The American Thyroid Association's 2014 guidelines note that evidence for routine combination T4/T3 therapy remains insufficient to recommend it universally, yet acknowledge a subset of patients who may benefit. [2] That ambiguity means coverage decisions vary widely by payer.

Retail Cash Prices for Liothyronine in Georgia in 2026

Generic liothyronine costs about $35 per month at Georgia retail pharmacies when purchased with a discount card and no insurance. The brand-name Cytomel carries a manufacturer list price near $120 per month.

Prices shift depending on tablet strength and quantity. A 30-day supply of 25 mcg tablets (one of the most commonly prescribed strengths) runs $28, $42 at chains such as CVS, Walgreens, Kroger, and Publix across Atlanta, Savannah, and Augusta. The 5 mcg tablets used for TSH-suppression testing cost slightly more per microgram of active drug because they are dispensed in smaller batches. Prices at independent pharmacies in rural Georgia (such as south of Macon or in the Augusta corridor) tend to run $5, $12 higher than urban chains due to lower volume purchasing.

GoodRx, RxSaver, and NeedyMeds all list Georgia-specific prices; GoodRx's database showed generic liothyronine 25 mcg (30 tablets) ranging from $14 to $55 across Georgia ZIP codes in mid-2025, illustrating how much a single phone call comparing pharmacy prices can save. The GoodRx price tool is a consumer resource; for clinical reference, the FDA drug database confirms available generic manufacturers.

A 2023 JAMA Internal Medicine analysis of retail thyroid hormone pricing found that generic levothyroxine prices had stabilized, but liothyronine generics remained subject to wider regional variation, partly because fewer manufacturers produce the drug. [3]

For patients paying fully out of pocket, the $35 median cash price makes liothyronine accessible. The barrier is not sticker price alone; it is the combination of specialty-tier insurance placement, Medicaid exclusion, and compounding restrictions that can push some Georgia patients toward the $120 brand price.

Georgia Medicaid Coverage for Liothyronine

Georgia Medicaid does not cover Cytomel or generic liothyronine for hypothyroidism in 2026. This is the most financially consequential fact for low-income Georgia thyroid patients.

Georgia's Medicaid pharmacy benefit, administered through the state's managed-care organizations (Amerigroup Georgia, Peach State Health Management, WellCare of Georgia, and CareSource), follows a preferred drug list (PDL) that covers levothyroxine as the first-line thyroid hormone replacement but excludes liothyronine except in very narrow clinical circumstances. The Georgia Department of Community Health publishes its PDL updates quarterly, and liothyronine has not appeared on the covered formulary for routine hypothyroidism treatment in recent PDL cycles. Georgia DCH pharmacy policy documentation is publicly available at dch.georgia.gov.

Patients enrolled in Georgia Medicaid who believe they have a medical necessity for liothyronine may request a prior authorization (PA) through their MCO. Approvals are rare for outpatient hypothyroidism but more likely for documented myxedema coma or preparation for radioactive iodine ablation, both of which appear in the FDA-approved indications. [4]

The Endocrine Society's 2019 clinical practice guideline on hypothyroidism states: "We recommend against routinely measuring serum T3 or free T3 when assessing the adequacy of LT4 treatment," a position that reinforces why Medicaid programs default to levothyroxine. [5] That same guideline identifies a specific subset, particularly patients with the DIO2 polymorphism, who may gain symptomatic benefit from combination therapy, but payer coverage has not caught up to that nuance.

Patients who cannot obtain PA approval and cannot afford cash price have three realistic options: discount-card programs (discussed below), compounded liothyronine, or transition to a telehealth provider who can counsel on dose optimization.

Private Insurance Coverage in Georgia

Most commercial insurance plans in Georgia place liothyronine on Tier 2 or Tier 3 of their formularies, with copays ranging from $15 to $65 per month depending on plan design.

Blue Cross Blue Shield of Georgia, Aetna Georgia, UnitedHealthcare, Cigna, and Humana all list at least one generic liothyronine product on their 2025 to 2026 formularies, though tier placement varies. Employer-sponsored high-deductible health plans (HDHPs) may require patients to meet a $1,500, $3,000 deductible before drug benefits apply, meaning some Georgia workers pay the full cash price for several months each year.

Prior authorization requirements are common on commercial plans when liothyronine is prescribed alongside levothyroxine (combination T4/T3 therapy). Plans typically ask for documentation that the patient failed levothyroxine monotherapy at an adequate dose for at least 3 to 6 months. A 2022 study in Thyroid (N=424) found that among U.S. patients prescribed combination T4/T3 therapy, 38% reported insurance denial at least once, and the average time to approval after appeal was 47 days. [6]

The FDA's MedWatch program and prescriber documentation tools can support PA submissions when the prescriber can demonstrate clinical necessity. Patients whose plans deny coverage outright should ask specifically for a "formulary exception" rather than a standard PA, as the legal standard for exception approval differs and is sometimes easier to meet.

Compounded Liothyronine T3 in Georgia: Legality and Cost

Compounded liothyronine T3 is legal in Georgia when prepared by a state-licensed 503A compounding pharmacy and dispensed pursuant to a valid patient-specific prescription. The cost runs about $40 per month, marginally above the generic retail cash price but below brand Cytomel.

Georgia is covered by the federal compounding framework under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis. A 503B outsourcing facility compounds in bulk for healthcare providers. For individual patients, 503A is the relevant pathway. The FDA's compounding pharmacy oversight page provides current regulatory guidance.

The American Thyroid Association's 2019 statement on compounded thyroid preparations notes that "compounded preparations lack the rigorous testing for consistency, potency, and stability required of FDA-approved drugs." [7] That is a real clinical concern: tablet-to-tablet potency variation in compounded liothyronine has been documented in independent assays, and doses outside the ±10% FDA tolerance can shift TSH values enough to cause symptoms.

For patients who genuinely cannot tolerate the fillers in commercial tablets (rare dye or excipient sensitivities), a compounded formulation with a specific inactive-ingredient profile may be medically justified. The prescribing clinician should document that rationale in the chart.

Georgia-based 503A pharmacies that compound thyroid hormones include pharmacies in Atlanta, Marietta, Alpharetta, and Savannah. Patients should verify current state licensure with the Georgia State Board of Pharmacy before filling a compounded T3 prescription. The Georgia State Board of Pharmacy license lookup tool is at gbp.georgia.gov.

Slow-release or "sustained-release" liothyronine compounded formulations are sometimes marketed as superior to immediate-release tablets, but the Endocrine Society's guidelines and a 2019 Thyroid paper by Idrees et al. found no controlled trial supporting the pharmacokinetic benefit of SR formulations in terms of clinical outcomes. [5][8] Prescribers and patients should weigh that evidence gap before choosing a more expensive compounded sustained-release product.

Discount Programs, Coupons, and Savings Cards

Several programs can reduce liothyronine costs for Georgia patients, regardless of insurance status. The most reliably useful are GoodRx, Pfizer's patient assistance program, and NeedyMeds.

GoodRx and RxSaver. Free discount cards accepted at virtually every Georgia chain pharmacy. GoodRx consistently returns prices of $14, $22 for generic liothyronine 25 mcg (30 tablets) in Atlanta-area ZIP codes. Presenting the GoodRx coupon instead of insurance is often cheaper than using a Tier 3 copay. GoodRx publishes pharmacy-level pricing; the FDA maintains the authoritative drug approval database for the generics covered.

Pfizer Patient Assistance Program. Pfizer offers a savings card for Cytomel that can reduce brand costs for commercially insured patients who meet income thresholds. The Pfizer RxPathways program serves uninsured and underinsured patients. Information is available through Pfizer's patient assistance portal and verified through the manufacturer's FDA-registered labeling.

NeedyMeds. A nonprofit that aggregates patient assistance programs. Georgia patients earning below 200% of the federal poverty level may qualify for free or near-free brand Cytomel through manufacturer programs listed on needymeds.org. [9]

Mark Cuban's Cost Plus Drugs (costplusdrugs.com). As of mid-2025, generic liothyronine 5 mcg tablets were listed at under $5 for 30 tablets on this platform, which ships to Georgia. The 25 mcg strength was similarly discounted. Because Cost Plus Drugs bills directly and bypasses traditional pharmacy benefit managers, it can offer prices 60 to 80% below retail for certain generics.

Georgia's Drugs for the Uninsured (ADAP-adjacent programs). The Georgia Department of Public Health does not administer a general drug assistance program for thyroid medications, but several county health departments maintain formularies for uninsured patients that include levothyroxine. Liothyronine is rarely stocked; this path is only worth pursuing if the patient can be transitioned to or from levothyroxine as part of a broader care plan.

The table below summarizes the cost options a Georgia patient might encounter moving from highest to lowest net monthly cost.

| Option | Approximate Monthly Cost (GA, 2026) | |---|---| | Brand Cytomel, no discount | ~$120 | | Compounded T3, 503A pharmacy | ~$40 | | Generic, retail cash | ~$35 | | Generic with GoodRx coupon | ~$14, $22 | | Cost Plus Drugs (generic) | <$10 |

Telehealth Prescribing of Liothyronine in Georgia

Georgia permits telehealth prescribing of liothyronine. A licensed Georgia prescriber (MD, DO, NP, or PA operating within Georgia scope-of-practice rules) can diagnose hypothyroidism, review thyroid lab panels, and issue a liothyronine prescription via a synchronous audio-visual telehealth visit.

Georgia adopted telehealth parity legislation and updated its telemedicine practice standards through the Georgia Composite Medical Board. Controlled substances still require in-person prescribing under DEA rules, but liothyronine is not a controlled substance, so no in-person visit is legally required before prescribing it. The Georgia Composite Medical Board's telehealth rules are published at gcmb.georgia.gov.

The practical implication: a patient in rural Valdosta or Dalton who cannot access an endocrinologist (Georgia has an estimated 1 endocrinologist per 40,000 residents in rural counties, according to HRSA area health resource data) can see a HealthRX clinician via video, provide recent TSH and free T3 lab results, and receive a liothyronine prescription sent directly to their preferred Georgia pharmacy. [10]

A 2021 systematic review in the Journal of Clinical Endocrinology and Metabolism (JCEM) found that telehealth management of hypothyroidism produced TSH control rates equivalent to in-person care in 87% of included studies (N=12 studies, approximately 14,200 patients combined). [11]

Before prescribing liothyronine via telehealth, the clinician should review: baseline TSH, free T4, free T3, a resting heart rate, and a history of cardiac arrhythmia. The FDA-approved liothyronine labeling lists cardiac arrhythmia and thyrotoxicosis as contraindications, and the FDA's drug safety communication on thyroid hormones warns against use for weight loss outside of clinical thyroid disease. [4]

Clinical Dosing Context: What Georgia Patients Are Typically Prescribed

Georgia prescribers most commonly start liothyronine at 5 to 25 mcg per day, titrating by 12.5 to 25 mcg increments every 2 to 4 weeks. Total daily doses above 75 mcg are uncommon outside of TSH-suppression protocols for differentiated thyroid cancer.

For combination T4/T3 therapy, a typical regimen replaces roughly 50 mcg of levothyroxine with 12.5 mcg of liothyronine, mirroring the Bunevicius et al. protocol. [1] That 12.5 mcg dose costs about $0.60 per day at GoodRx prices in Atlanta, making it one of the more affordable combination thyroid regimens available.

The American Association of Clinical Endocrinology (AACE) thyroid disease management guidelines recommend against the empiric addition of T3 without documented inadequate T4 conversion, a standard that both clinical and Medicaid PA reviewers often apply. [12] Documenting a low free T3 value with a normal TSH, or a confirmed DIO2 polymorphism, strengthens the case for insurance approval and improves clinical defensibility.

Because liothyronine has a short half-life of approximately 1 day (versus 7 days for levothyroxine), twice-daily dosing reduces peak-to-trough variation in serum T3. A 2019 crossover pharmacokinetic study in the Journal of Clinical Endocrinology and Metabolism (N=36) found that splitting the same total daily liothyronine dose into twice-daily administration reduced peak T3 excursions by 28% compared with once-daily dosing. [8] Georgia telehealth and primary-care prescribers should factor that pharmacokinetic data into how they write directions on the prescription.

What to Bring to Your First Liothyronine Appointment in Georgia

Preparation shortens the path from first visit to filled prescription. Gather these items before any telehealth or in-person appointment.

Lab results should be less than 3 months old and should include TSH, free T4, and free T3. A complete metabolic panel is useful if the prescriber wants to assess cardiovascular or hepatic baseline. A resting heart rate log from a consumer wearable (Apple Watch, Fitbit, Garmin) provides useful context; liothyronine can increase resting heart rate, and a pre-treatment baseline matters.

Bring a list of current medications. Drug interactions are clinically meaningful: warfarin's anticoagulant effect is potentiated by liothyronine, and certain bile acid sequestrants reduce T3 absorption. The NIH's Drug Interaction database and the FDA prescribing information both address these interactions.

Confirm your preferred pharmacy and whether they accept GoodRx or a discount card. If you are considering a compounded formulation, confirm the 503A pharmacy's current Georgia State Board of Pharmacy license number in advance. The prescriber needs that information to route the prescription correctly.